Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Schlossberg Insider Profile

11 Followers

Mark Schlossberg, SVP - Legal & General Counsel at Cytokinetics, holds 103.41K shares in Cytokinetics (Ticker: CYTK), holds 0.00 shares in Amneal Pharmaceuticals (Ticker: AMRX), holds 0.00 shares in ImmunoCellular Therapeutics (Ticker: IMUC).

Mark Schlossberg's Trading History

CYTK
Cytokinetics
Mar 15, 2022SVP - Legal & General CounselUninformative Buy648.64K$5.50M
AMRX
Amneal Pharmaceuticals
May 08, 2018SVP & GCUninformative Sell―$0.00
IMUC
ImmunoCellular Therapeutics
―Director―$0.00

You May Also Like

Mark Schlossberg insider profile FAQ

What is the percentage of profitable transactions made by Mark Schlossberg?
The percentage of profitable transactions made by Mark Schlossberg is 67%.
What is the average return per transaction made by Mark Schlossberg?
The average return per transaction made by Mark Schlossberg is 25.90%.
What stocks does Mark Schlossberg hold?
Mark Schlossberg holds: CYTK, AMRX, IMUC stocks.
What was Mark Schlossberg’s latest transaction?
Mark Schlossberg’s latest transaction was an Uninformative Buy of $648.64K.
What was Mark Schlossberg's most profitable transaction?
Mark Schlossberg’s most profitable transaction was an Informative Sell of AMRX stock on August 27, 2015. The return on the trade was 45.50%.
What is Mark Schlossberg's role in Cytokinetics?
Mark Schlossberg's role in Cytokinetics is SVP - Legal & General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.